119 related articles for article (PubMed ID: 16397176)
1. Anticoagulation intensity and stroke during warfarin-use in atrial fibrillation patients.
Hart RG
Stroke; 2006 Feb; 37(2):334; author reply 334-5. PubMed ID: 16397176
[No Abstract] [Full Text] [Related]
2. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.
Gladstone DJ; Bui E; Fang J; Laupacis A; Lindsay MP; Tu JV; Silver FL; Kapral MK
Stroke; 2009 Jan; 40(1):235-40. PubMed ID: 18757287
[TBL] [Abstract][Full Text] [Related]
3. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
[TBL] [Abstract][Full Text] [Related]
4. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.
Yang X; Li Z; Zhao X; Wang C; Liu L; Wang C; Pan Y; Li H; Wang D; Hart RG; Wang Y; Wang Y;
Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643
[TBL] [Abstract][Full Text] [Related]
5. Are cost benefits of anticoagulation for stroke prevention in atrial fibrillation underestimated?
Miller PS; Andersson FL; Kalra L
Stroke; 2005 Feb; 36(2):360-6. PubMed ID: 15637326
[TBL] [Abstract][Full Text] [Related]
6. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.
Hylek EM; Skates SJ; Sheehan MA; Singer DE
N Engl J Med; 1996 Aug; 335(8):540-6. PubMed ID: 8678931
[TBL] [Abstract][Full Text] [Related]
7. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
[TBL] [Abstract][Full Text] [Related]
8. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
[TBL] [Abstract][Full Text] [Related]
9. Ischemic stroke on optimal anticoagulation with novel-oral anticoagulants compared with warfarin.
Kim BJ; Kang HG; Lee DH; Kang DW; Kim JS; Kwon SU
Int J Stroke; 2015 Aug; 10(6):E68. PubMed ID: 26202718
[No Abstract] [Full Text] [Related]
10. International normalized ratio stability in warfarin-experienced patients with nonvalvular atrial fibrillation.
Nelson WW; Desai S; Damaraju CV; Lu L; Fields LE; Wildgoose P; Schein JR
Am J Cardiovasc Drugs; 2015 Jun; 15(3):205-11. PubMed ID: 25944648
[TBL] [Abstract][Full Text] [Related]
11. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
Ho CW; Ho MH; Chan PH; Hai JJ; Cheung E; Yeung CY; Lau KK; Chan KH; Lau CP; Lip GY; Leung GK; Tse HF; Siu CW
Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148
[TBL] [Abstract][Full Text] [Related]
12. Disparate stroke rates on warfarin among contemporaneous cohorts with atrial fibrillation: potential insights into risk from a comparative analysis of SPORTIF III versus SPORTIF V.
Hylek EM; Frison L; Henault LE; Cupples A
Stroke; 2008 Nov; 39(11):3009-14. PubMed ID: 18703812
[TBL] [Abstract][Full Text] [Related]
13. Amiodarone for atrial fibrillation.
Kurnik D; Loebstein R; Olchovsky D
N Engl J Med; 2007 Jun; 356(23):2424-6; author reply 2424-6. PubMed ID: 17561530
[No Abstract] [Full Text] [Related]
14. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation intensity for elderly atrial fibrillation patients: should we use a conventional INR target (2.0 to 3.0) or a lower range?
Lane DA; Lip GY
Thromb Haemost; 2010 Feb; 103(2):254-6. PubMed ID: 20076858
[No Abstract] [Full Text] [Related]
16. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.
Wallentin L; Lopes RD; Hanna M; Thomas L; Hellkamp A; Nepal S; Hylek EM; Al-Khatib SM; Alexander JH; Alings M; Amerena J; Ansell J; Aylward P; Bartunek J; Commerford P; De Caterina R; Erol C; Harjola VP; Held C; Horowitz JD; Huber K; Husted S; Keltai M; Lanas F; Lisheng L; McMurray JJ; Oh BH; Rosenqvist M; Ruzyllo W; Steg PG; Vinereanu D; Xavier D; Granger CB;
Circulation; 2013 Jun; 127(22):2166-76. PubMed ID: 23640971
[TBL] [Abstract][Full Text] [Related]
18. Oral anticoagulation and stroke in atrial fibrillation.
Epstein EF; Natarajan I
N Engl J Med; 2003 Dec; 349(24):2360-1; author reply 2360-1. PubMed ID: 14674042
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis.
Hijazi Z; Hohnloser SH; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Siegbahn A; Yusuf S; Wallentin L
Circulation; 2014 Mar; 129(9):961-70. PubMed ID: 24323795
[TBL] [Abstract][Full Text] [Related]
20. Warfarin--indications, risks and drug interactions.
Tadros R; Shakib S
Aust Fam Physician; 2010 Jul; 39(7):476-9. PubMed ID: 20628660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
